Aptar Reports 2019 Fourth Quarter and Annual Results

Aptar Reports Fourth Quarter and Annual Results; Recaps Year of Pharma Services Acquisitions and Multiple New Drug Delivery Launches; Highlights Strategic Steps to Strengthen Beauty Business

Crystal Lake, Illinois, February 20, 2020 — AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions and services, today reported its fourth quarter and full year 2019 financial results.

Fourth Quarter 2019 Summary

  • Reported sales decreased 2% and were negatively affected by changes in currency exchange rates
  • Core sales, excluding currency and acquisition effects, declined 1% including a negative impact from passing on lower resin costs
  • Core sales growth in our Pharma segment was offset by decreases in core sales in our other segments
  • Reported earnings per share of $0.73 (up 18% compared to the prior year)
  • Adjusted earnings per share of $0.80 (down 13% compared to the prior year)
  • Reported net income of $49 million (up 19% compared to the prior year)
  • Adjusted EBITDA of $131 million (down 7% compared to the prior year)
  • Subsequent to the end of the quarter:
    • Completed the previously announced equity investment in BTY, a leading Chinese provider of decorative and complete color cosmetics packaging solutions
    • As previously announced, entered into a binding agreement to acquire FusionPKG, a design and rapid go-to-market specialist for the North American beauty market
    • Announced plans to consolidate North American Beauty + Home footprint

Annual 2019 Summary

  • Reported sales increased 3%
  • Core sales, excluding currency and acquisition effects, grew 3%
  • Reported earnings per share of $3.66 (up 22% compared to the prior year)
  • Adjusted earnings per share of $3.95 (up 2% compared to the prior year)
  • Reported net income of $242 million (up 24% compared to the prior year)
  • Adjusted EBITDA of $592 million (up 8% compared to the prior year)
  • Net cash provided by operations of $514 million
  • Free cash flow of $272 million
  • Raised cash dividend 6% and achieved our 26th consecutive year of paying increased dividends
  • Returned $177 million to shareholders for the year in dividends and share repurchases
  • Acquired strategic Pharma services (Nanopharm, Gateway Analytical, Noble International)
  • Made strategic investment in sustainable solutions partners PureCycle and Terracycle’s Loop
  • Named one of America’s Most Responsible Companies by Newsweek
  • Named one of America’s Most Sustainable Companies by Barron’s

Download the full press release